Dyclopro Solution
NDC Package 0362-3971-05
Package Information
Dyclopro (dyclonine hydrochloride) solution is dyclonine HCl Topical Solution, USP is indicated for anesthetizing accessible mucous membranes (e.g., the mouth, pharynx, larynx, trachea, esophagus, and urethra) prior to various endoscopic procedures.Dyclonine HCl Topical Solution, USP, 0.5% topical anesthetic may also be used to block the gag reflex, to relieve the pain of oral ulcers or stomatitis and to relieve pain associated with ano-genital lesions. This formulation utilizes a solution delivery system. Marketed by Septodont Inc, this product is identified by NDC 0362-3971 and is authorized under FDA application ANDA200480.
Identification & Billing
- RxCUI: 1048281 - dyclonine HCl 0.5 % Mucous Membrane Topical Solution
- RxCUI: 1048281 - dyclonine hydrochloride 5 MG/ML Mucous Membrane Topical Solution
- RxCUI: 1048281 - dyclonine hydrochloride 0.5 % Mucous Membrane Topical Solution
- RxCUI: 2199132 - DycloPro 0.5 % Mucous Membrane Topical Solution
- RxCUI: 2199132 - dyclonine hydrochloride 5 MG/ML Mucous Membrane Topical Solution [Dyclopro]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0362 - Septodont Inc
- 0362-3971 - Dyclopro
- 0362-3971-05 - 1 BOTTLE in 1 BOTTLE / 30 mL in 1 BOTTLE
- 0362-3971 - Dyclopro
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0362-3971-05 identifies a specific commercial package of 1 bottle in 1 bottle / 30 ml in 1 bottle of Dyclopro, a human prescription drug labeled by Septodont Inc. This solution is formulated for topical use and contains dyclonine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Septodont Inc on September 01, 2019. The current certification is valid through December 31, 2026.
How is this Septodont Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00362397105. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.